Poly Medicure Limited (NSE:POLYMED)
India · Delayed Price · Currency is INR 1,693.70
-27.20 (-1.58%)
Jul 21, 2026, 10:54 AM IST
Poly Medicure Market Cap
Poly Medicure has a market cap or net worth of 174.5 billion as of July 20, 2026. Its market cap has decreased by -18.27% in one year.
Market Cap
174.50B
Enterprise Value
170.19B
Revenue
18.75B
Ranking
n/a
PE Ratio
54.17
Stock Price
1,693.70
ChartMarket Cap Chart
Since November 19, 2004, Poly Medicure's market cap has increased from 324.00M to 174.50B, an increase of 53,756.61%. That is a compound annual growth rate of 33.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 170.33B | -5.37% |
| Dec 31, 2025 | 179.99B | -31.93% |
| Dec 31, 2024 | 264.42B | 84.87% |
| Dec 29, 2023 | 143.03B | 66.54% |
| Dec 30, 2022 | 85.89B | -6.43% |
| Dec 31, 2021 | 91.79B | 105.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.64T |
| Divi's Laboratories | 1.92T |
| Apollo Hospitals Enterprise | 1.27T |
| Cipla | 1.15T |
| OneSource Specialty Pharma | 189.53B |
| NATCO Pharma | 169.26B |
| Cohance Lifesciences | 169.06B |
| Syngene International | 166.19B |